RecruitingNot ApplicableNCT07211243

Suprasorb®X+PHMB Pro vs Suprasorb®X+PHMB in Treatment of Infected Venous Leg Ulcers

Multicenter, Randomised in Parallel Groups, Controlled Study to Compare Performance and Safety of Suprasorb®X+PHMB Pro With Suprasorb® X+PHMB Dressing in Treatment of Infected Venous Leg Ulcers


Sponsor

Lohmann & Rauscher

Enrollment

150 participants

Start Date

Sep 23, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This clinical investigation will be conducted as a multicentre, open-label, randomised in parallel groups, controlled study on patients with infected venous leg ulcers.


Eligibility

Min Age: 18 Years

Inclusion Criteria5

  • Age ≥ 18 years
  • Infected\* venous\*\* leg ulcer
  • Slightly to moderately exuding wound\*\*\*
  • Patient has signed informed consent
  • as per CDC definition, also TILI score ≥ 5 \*\* ABPI \> 0.8 and \< 1.2 \*\*\* patients with highly exuding wounds may be screened for a 7 days run-in period to receive superabsorbent dressing and monitored compression therapy and re-con-sidered for enrolment in case the exudation level decreases

Exclusion Criteria5

  • Participation in other interventional clinical trial that could interfere with the present study within 4 weeks of the randomisation and during the whole duration of this study
  • Wounds with exposed cartilage tissue (hyaline cartilage)
  • Contraindications to compression therapy (e.g.: advanced peripheral ar-terial occlusive diseases, decompensated cardiac insufficiency, septic phlebitis, phlegmasia coerulea dolens, sensation disorders of the skin)
  • Known allergy and/or hypersensitivity to any components of the study product or concomitant products (e.g. compression bandage)
  • Any other medical condition, which, by opinion of the investigator, may have impact of the success of the study treatment and / or interpreta-tion of the study results.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEPHMB-impregnated biocellulose wound dressing with additional polyethylene film on top, compression therapy, systemic antomicrobial therapy (optional)

Application of a wound dressing with additional polyethylene film on top and compression therapy. Optional usage of the systemic antimicrobial therapy.

DEVICEPHMB-impregnated biocellulose wound dressing without additional polyethylene film on top, compression therapy, systemic antomicrobial therapy (optional)

Application of a wound dressing without additional polyethylene film on top and compression therapy. Optional usage of the systemic antimicrobial therapy.


Locations(9)

ClinicMed Daniluk, Nowak Spółka Komandytowa OŚRODEK LECZENIA RAN i Owrzodzeń

Bialystok, Poland

Centrum Medyczne Ultramed

Krakow, Poland

MelissaMed Poradnia Chirurgiczna

Lodz, Poland

Mikomed Spółka Z Ograniczoną Odpowiedzialnością

Lodz, Poland

Niepubliczny Zakład Opieki Zdrowotnej "Argo" Centrum Medyczne

Lodz, Poland

PP CLINIC Pietrzyk spółka partnerska lekarzy

Lublin, Poland

SPECJALISTYCZNY OSRODEK LECZNICZO BADAWCZY, Zbigniew Żęgota

Ostróda, Poland

Lecran - Centrum Opieki Nad Ranami-Kunickiego

Wroclaw, Poland

Specjalistyczna Pomoc Medyczna "Medservice"

Zabrze, Poland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07211243


Related Trials